Actively Recruiting
Study on Psychological Distress and Its Impact on Treatment and Quality of Life in Adults with Malignant Tumors
Led by Gang Chen, MD · Updated on 2025-09-25
2000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how psychological distress affects patients with malignant tumors in terms of their treatment adherence, treatment outcomes, and quality of life. The study aims to understand whether having psychological distress can impact these factors in patients diagnosed with cancers such as hepatobiliary carcinoma, gastric cancer, breast cancer, and lung cancer. This observational study includes patients both with and without psychological distress to compare their experiences. Participants will be divided into two groups based on whether they have psychological distress or not. They will complete questionnaires including the GAD-7 and PHQ-9 to assess anxiety and depression levels. Their treatment adherence, clinical outcomes, and quality of life will be recorded and monitored over a three-year period to gather comprehensive data. During the study, patients will undergo regular assessments to measure their response to treatment using the Objective Response Rate ORR by mRECIST within 4 to 12 weeks after starting treatment. Researchers will also collect ongoing data about their psychological status and treatment progress over three years. The study is observational, so no experimental treatment is given, and participants will continue their usual care while contributing valuable information about the role of psychological distress in cancer treatment.
CONDITIONS
Brief Title
Psychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of Life
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here